跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,022 条关于
“amyloid light-chain (AL) amyloidosis”
全部
14,022
临床试验
9,386
药物
551
机构
111
资讯
3,974
2年前
FDA Grants Orphan Drug Designation to Immix Biopharma's NXC-201 for AL Amyloidosis
9个月前
Protego Biopharma Raises $130M to Advance Novel Protein Stabilization Approach for AL Amyloidosis
2年前
NXC-201 CAR T-Cell Therapy Shows Promise in Relapsed/Refractory AL Amyloidosis
去年
European Commission Grants Orphan Drug Designation to Florbetaben (18F) for ATTR Amyloidosis Diagnosis
3个月前
AstraZeneca's Anselamimab Shows 62% Survival Improvement in Kappa Light Chain Amyloidosis Despite Missing Primary Endpoint
3个月前
Attralus' Zamubafusp Alfa Receives FDA Orphan Drug Designation for AL Amyloidosis
去年
AstraZeneca's Anselamimab Fails Primary Endpoint in Phase III AL Amyloidosis Trial, Shows Promise in Patient Subgroup
去年
Immix Biopharma's NXC-201 Advances to Expansion Cohort in US AL Amyloidosis Trial
8个月前
Bayer Acquires Pan-Amyloid Imaging Agents from Attralus to Advance Cardiac Amyloidosis Diagnosis
8年前
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]florbetaben in Cardiac Amyloidosis Diagnosis
第 1 页，共 398 页
上一页
下一页
